2021, Number 1
<< Back Next >>
Bol Clin Hosp Infant Edo Son 2021; 38 (1)
Scorpion sting poisoning and its outpatient treatment in the Hospital Infantil del Estado de Sonora
Frías-Mendívil M, García-Pérez MC, Canales-Guerrero CJ, Valdez-Haro A, Cano-Rangel MA, Martínez-Medina MÁ, Martínez-Carballo ÉM, Monroy-Zúñiga ÉA
Language: Spanish
References: 16
Page: 13-21
PDF size: 164.60 Kb.
ABSTRACT
In 2018 Scorpion Sting Envenomation (SSE) in Mexico occurred 19,966 times in children under 5 years of age. In
Sonora, the
Centruroides sculpturatus sting causes neuromotor excitation syndrome that requires specific antiven. The
objective of this work was to describe the ABSTRACT
In 2018 Scorpion Sting Envenomation (SSE) in Mexico occurred 19,966 times in children under 5 years of age. In
Sonora, the Centruroides sculpturatus sting causes neuromotor excitation syndrome that requires specific antiven. The
objective of this work was to describe the clinical characteristics and treatment of the outpatient in children with SSE at
the Hospital Infantil del Estado de Sonora (HIES) from 2017 to 2018. The clinical notes of the Emergency Service of the
children who were treated during that period with SSE and, without serious or hospitalized intoxication. Epidemiological
and clinical variables were analyzed in children under 18 years old; with the information obtained, a descriptive analysis
was carried out by mean, standard deviation and frequency and percentage. The 279 cases were analyzed, school-age
children were the most affected (41.2%), and 55.8% presented mild intoxication SSE. Pain was observed in 65.9% and
the 72.6% of the children, they received at least one vial of drug therapy and 55.9% of the boys with mild SSE only
received one vial with satisfactory results. None of the children who received drug therapy presented adverse events or
required hospitalization, only one child received six vials and the administration of the drug in less than 4 hours decreased
the percentage of children with serious neurotoxic effects.
REFERENCES
Secretaría de Salud. Anuario de Morbilidad 1984- 2019. 20 Principales causas de enfermedad nacional. Disponible en:https://epidemiologia.salud.gob.mx/ anuario/html/principales_nacional.hm
Secretaría de Salud. Dirección General en Información en Salud. Cubos Dinámicos. Disponible en:http:// www.dgis.salud.gob.mx/contenidos/basesdedatos/ bdc_defunciones_gobmx.html.
Possani LD, Becerril B, Delepierre M, Tytgat J. Scorpion toxins specific for Na+‐channels. Eur J Biochem. 1999; 264: 287-300.
Isbister GK, Bawaskar HS. Scorpion Envenomation. N Engl J Med. 2014; 371:457-63.
Santibáñez-López, C, Francke O, Ureta C, Possani, L. Scorpions from Mexico: From Species Diversity to Venom Complexity. Toxins (Basel). 2015; 8: 1-18.
Rodrigo CH, Gnanathasan A. Management of scorpion envenoming: a systematic review and meta- analysis of controlled clinical trials. Suystematic Reviews. 2017; 6: 74-85.
Martínez MA, Villalobos L, Solís MA. Experiencia en manejo de antisuero en intoxicación por picadura de alacrán en el Hospital Infantil del Estado de Sonora (Tesis posgrado). 2011; Universidad Nacional Autónoma de México. Sonora, México.
Norma Oficial Mexicana NON-033-SSA2-2011, Para la vigilancia, prevención y control de la intoxicación por picadura de alacrán. Publicada en Diario Oficial de la Federación, México, DOF: 08/12//2011. Disponible en:www.hcg.udg.mx/PAGs/Sec_Transparencia/ PDFs_Transparencia/II_E_NOM_27.pdf
Programa de Acción Específico. Prevención y Control de la Intoxicación por Picadura de Alacrán 2013-2018. Programa Sectorial de Salud. Secretaría de Salud. Disponible en: https://www.gob.mx/cms/ uploads/attachment/file/266418/PAE_Prevencion- ControlIntoxicacionPicaduraAlacran2013_2018.pdf
Ponce-Saavedra J, Francke BOF. Clave para la identificación de especies de alacranes del género Centruroides Marx 1890 (Scorpiones: Buthidae) en el Centro Occidente de México. Biológicas. 2013; 15(1): 52 - 62.
1Martínez MA, Rubio LJ, Encinas MG, Gómez VJ. Picadura por alacrán estudio 100 casos. Bol Clín Hosp Infan Méx. 1983; 40: 707-710.
Skolnik AB, Ewald MB. Pediatric scorpion envenomation in the United States. Morbidity, mortality, and therapeutic innovations. Pediatr Emer Care. 2013; 29(1): 98-106.
Dehghankhalili M, Mobaraki H, Akbarzadeh A, Yazdani R, Nazemi A, Ghaffarpasand F, et al. Clinical and Laboratory Characteristics of Pediatric Scorpion Stings: A Report From Southern Iran. Pediatr Emerg Care. 2017; 33(6): 405-408.
1Abimannane A, Rameshkumar R, Satheesh P, Mahadevan S. Second dose of scorpion antivenom in children with Indian Red Scorpion (Mesobuthus tamulus) sting envenomation. Indian Pediatr. 2018; 55(4): 315-18.
Boyer LV, Theodorou AA, Berg RA, Mallie J, Chávez- Méndez A, García- Ubbelohde W. Antivenom for critically ill children with neurotoxicity from scorpion stings. N Engl J Med. 2009; 360(20): 2090- 98.
Bahloul M, Chabchoub I, Chaari A, Chtara K, Kallel H, Dammak H. Scorpion envenomation among children: clinical manifestations and outcome (analysis of 685 cases). Am J Trop Med Hyg. 2010; 83(5): 1084-92.